ARTICLE | Clinical News
Aptivus tipranavir regulatory update
May 4, 2009 7:00 AM UTC
EMEA's CHMP issued a positive opinion to extend the indication for Aptivus tipranavir from Boehringer Ingelheim to include the treatment of HIV in highly pre-treated adolescents aged 12 and older resi...